When PARP Inhibitors Fail in Ovarian Cancer

March 19, 2019 1:03 PM | Deleted user

March 19, 2019, MedPage Today 

Lack of response to a PARP inhibitor in epithelial ovarian cancer didn't necessarily mean patients were resistant to all such agents, a small retrospective study indicated. 

Read more.

Powered by Wild Apricot Membership Software